KMA and Co.
  • Why
  • Who
  • What
  • Where
  • Case Studies
  • Reports
  • Blog
Select Page
Digital Therapeutics is Primed for a Return to the Roaring 20’s

Digital Therapeutics is Primed for a Return to the Roaring 20’s

by Cassie Arnold | Apr 20, 2021 | Deal making, Digital Health, Digital Therapeutic, Investment, Modern Work, Venture capital

For 2021, our data partner DealForma is providing venture investment data in addition to the data they have been sharing on M&A deals.  As we all know, VC investment was on a roll in 2020. Silicon Valley Bank has reported that venture investment in...
Counting Deals Instead of Votes

Counting Deals Instead of Votes

by Cassie Arnold | Nov 10, 2020 | Biotech Finance, Deal making, Digital Health, Digital Therapeutic

Tired from a long week of parsing electoral college votes? How about focusing on digital therapeutic deals for a change of pace? The third quarter brought a record number of digital therapeutic deals with a total of 19. That’s up from 16 in the previous quarter. The...
Acquisitions Fuel Digital Therapeutic Dealmaking in Q2

Acquisitions Fuel Digital Therapeutic Dealmaking in Q2

by Cassie Arnold | Jul 8, 2020 | Deal making, Digital Health, Digital Therapeutic, Investment

Digital therapeutic dealmaking bounced back to Q4 2019 levels in the second quarter of the year. After a first quarter where deal-making was stymied in by the onslaught of COVID-19, buyers came back big-time in the second quarter once the reality of the “new...
Digital Therapeutic Deals in a Time of COVID-19

Digital Therapeutic Deals in a Time of COVID-19

by Cassie Arnold | Apr 21, 2020 | Deal making, Digital Health, Digital Therapeutic, Investment

First quarter digital therapeutic deal data provided by DealForma shows a drop quarter-over-quarter from 16 transactions in the last quarter of 2019 to 11 in the first quarter of 2020. But year-over-year, the first quarter of 2020 is on par with the first quarter of...
Tracking Digital Therapeutics

Tracking Digital Therapeutics

by Cassie Arnold | Feb 25, 2020 | Biotech Finance, Digital Health, Digital Therapeutic

When I started following the digital health sector in earnest about ten years ago, I was intrigued with the potential of digital technology to treat disease – the so-called digital therapeutics. Instead, the sector produced an almost infinite variety of activity...

Newsletter

Subscribe for notifications of new posts, and occasional other news from KMA & Company.




Recent Posts

  • Opportunity Costs
  • Let Me Repeat That
  • Numbers Tell Stories
  • Five Bits of Advice on MarCom Tactics
  • TL;DR*, Less is More, Short and Sweet

Categories

  • 21st Century Culture
  • Advertising
  • Biotech Finance
  • Branding
  • Communications
  • COVID
  • Deal making
  • Digital Health
  • Digital Therapeutic
  • Digital Therapeutics
  • Gender at Work
  • Investment
  • Modern Work
  • Persuasion
  • Sales
  • Venture capital
  • X
  • RSS
Copyright © 2025 KMA & Company